Iranian Amir Heshmatpour, CEO of NeOnc Technologies, is to start trials of his brain cancer treatment at Tel Aviv’s Sourasky (Ichilov) hospital. Nasally-administered NeOnc bypasses the blood-brain barrier. Trials will include stage 3 and 4 patients. 24 patients are in remission.
https://unitedwithisrael.org/iranian-businessman-holds-clinical-trials-in-israel-for-cancer-drug/